Skip to main content
SpringerLink
Log in

Doggone It—The Case Is Cancelled

Fatal Forty DDI: midazolam, lopinavir/ritonavir, CYP3A4

  • Chapter
A Case Approach to Perioperative Drug-Drug Interactions

  • 76 Accesses

Abstract

This case discusses a pharmacokinetic drug interaction between midazolam and ritonavir/lopinavir. Midazolam is a cytochrome P450 3A4 substrate and ritonavir/lopinavir is a 3A4 inhibitor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yeh RF, Gaver VE, Patterson KB, et al. Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers. J Acquir Immune Defic Syndr. 2006;42(1):52–60.

    PubMed  CAS  Google Scholar 

  2. Wyen C, Fuhr U, Frank D, et al. Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients. Clin Pharmacol Ther. 2008;84(1):75–82.

    Article  PubMed  CAS  Google Scholar 

  3. Product information: Kaletra tablets (lopinavir/ritonavir). North Chicago: Abbott Laboratories; 2011.

    Google Scholar 

  4. Hsu AJ, Carson KA, Yung R, Pham PA. Severe prolonged sedation associated with coadministration of protease inhibitors and intravenous midazolam during bronchoscopy. Pharmacotherapy. 2012;32(6):538–45.

    Article  PubMed  CAS  Google Scholar 

  5. Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet. 2000;38:41–57.

    Article  PubMed  CAS  Google Scholar 

  6. Kirby BJ, Collier AC, Kharasch ED, Dixit V, Desai P, Whittington D, Thummel KE, Unadkat JD. Complex drug interactions of HIV protease inhibitors 2: in vivo induction and in vitro to in vivo correlation of induction of cytochrome P450 1A2, 2B6, and 2C9 by ritonavir or nelfinavir. Drug Metab Dispos. 2011;39(12):2329–37. Epub 2011 Sep 19.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. HIV InSite, Database of antiretroviral drug Interactions, interactions with Midazolam (Versed) and antiretrovirals, University of California, San Francisco. http://hivinsite.ucsf.edu/insite?page=ar-00-02&post=8&param=73#60. Accessed 1/10/2012.

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA

    Erica D. Wittwer MD, PhD & Wayne T. Nicholson MD, PharmD, MSc

  2. Dunes Podiatry, Murrells Inlet, SC, USA

    Corinne Wisdo DPM

  3. Anesthesia Services Department, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA

    Catherine Marcucci MD

Authors
  1. Erica D. Wittwer MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wayne T. Nicholson MD, PharmD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Corinne Wisdo DPM
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Catherine Marcucci MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erica D. Wittwer MD, PhD .

Editor information

Editors and Affiliations

  1. Anesthesia Services Department, Philadelphia Veterans Affairs Med Center, Philadelphia, PA, USA

    Catherine Marcucci MD

  2. Department of Anesthesiology, Oregon Health and Science University, Portland, OR, USA

    Michael P. Hutchens MD

  3. Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA

    Erica D. Wittwer MD, PhD , Toby N. Weingarten MD , Juraj Sprung MD, PhD  & Wayne T. Nicholson MD, PharmD, MSc , ,  & 

  4. Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, OR, USA

    Kirk Lalwani MD

  5. Department of Anesthesiology, University of Pittsburgh School of Med Liliane S. Kaufmann Building, Pittsburgh, PA, USA

    David G. Metro MD

  6. Department of Anesthesiology, University of Illinois at Chicago, Chicago, IL, USA

    Randal O. Dull MD, PhD

  7. Department of Anesthesiology, Perioperative Medicine, Oregon Health and Science University, Portland, OR, USA

    Christopher E. Swide MD

  8. Department of Learning Health Sciences, University of Michigan Medical School, Ann Arbor, MI, USA

    F. Jacob Seagull PhD

  9. Department of Anesthesiology and Perioperative Medicine, Portland, OR, USA

    Jeffrey R. Kirsch MD (Professor and Chair) (Professor and Chair)

  10. Department of Psychiatry, University of Maryland Medical System VA Maryland Health Care System, Baltimore, MD, USA

    Neil B. Sandson MD

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wittwer, E.D., Nicholson, W.T., Wisdo, C., Marcucci, C. (2015). Doggone It—The Case Is Cancelled. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_84

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7495-1_84

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7494-4

  • Online ISBN: 978-1-4614-7495-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation